Eyes Over Copley Announces Maui Jim Trunk Show on June 10
Jun 01, 2017 11:07 am UTC| Business
BOSTON, June 01, 2017 -- Boston eye care clinic Eyes Over Copley has announced an upcoming trunk show featuring the full collection of Maui Jim sunglasses. The sale takes place on Saturday, June 10, 2017, and runs from...
Eyes Over Copley Announces Maui Jim Trunk Show on June 10
Jun 01, 2017 11:07 am UTC| Business
BOSTON, June 01, 2017 -- Boston eye care clinic Eyes Over Copley has announced an upcoming trunk show featuring the full collection of Maui Jim sunglasses. The sale takes place on Saturday, June 10, 2017, and runs from...
Eyes Over Copley Announces Maui Jim Trunk Show on June 10
Jun 01, 2017 11:07 am UTC| Business
BOSTON, June 01, 2017 -- Boston eye care clinic Eyes Over Copley has announced an upcoming trunk show featuring the full collection of Maui Jim sunglasses. The sale takes place on Saturday, June 10, 2017, and runs from...
Eyes Over Copley Announces Maui Jim Trunk Show on June 10
Jun 01, 2017 11:07 am UTC| Business
BOSTON, June 01, 2017 -- Boston eye care clinic Eyes Over Copley has announced an upcoming trunk show featuring the full collection of Maui Jim sunglasses. The sale takes place on Saturday, June 10, 2017, and runs from...
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
miRagen Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 11:06 am UTC| Business
BOULDER, Colo., June 01, 2017 -- Miragen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows